Tag Archives: CPD bag
The central government will spend ten billion comprehensive medical information system
Led by the Ministry, \"the pharmaceutical industry second Five\" coming soon, planning to set, \"five-second\" period, China\\ s pharmaceutical industry for more than 20% average annual growth of GDP in 2015 reached 3 trillion. Recently, China Pharmaceutical Enterprise Management Association, said in Matilda, the pharmaceutical industry and the increase in actual output value will exceed the target.
Matilda was in 2011 at the Fifth China Healthcare Industry Investment and Finance Summit to make such remarks. At the meeting, several industry experts and investment and financing sources have told reporters that countries have to encourage social capital to enter the healthcare industry, but the current policy remains unclear, agencies are generally in a wait period.
Agency said in 2015 China will become the world\\ s second largest pharmaceutical market
Led by the Ministry of the \"second Five pharmaceutical industry\" has not yet introduced, but the plan is initially set, \"five-second\" period, China\\ s pharmaceutical industry for more than 20% average annual growth of GDP in 2015 reached 3 trillion.
China Pharmaceutical Enterprise Management Association, said in Matilda, in 2015 total output value of China\\ s pharmaceutical industry is expected to reach 3600 to 3700 billion level; from the beginning of this year to 2015, average annual growth rate will reach 23-24%. \"At that time, Mr. Obama also eat on Chinese medicine, which is not a joke.\"
It is reported that the health care industry in developed countries usually accounts for GDP10%, while China is now the industry accounts for only about 4% of GDP. With urbanization, aging era, China\\ s healthcare industry is ushering in spring. According to related statistics, last year a total of over 60 companies of 60 billion investment, equivalent to the sum of the three years 2007,2008,2009.
VIVO Ventures Managing Partner Zhao Jin pointed out that China will surpass Japan in 2015 as the world\\ s second largest pharmaceutical market, the national medical costs in 2013 is expected to reach $ 356 million.
Investment in the future will become the focus of medical devices
China medical equipment Association Meng Jianguo, deputy Secretary-General said at the meeting to support the medical device industry will be the second Five-focus, this year the central government will spend billions of improving health care information systems, including the armed rural medical institutions; the same time, health Ministry allocated 2.45 billion yuan of special funds this year to give 450,000 village clinics configure computers and networks, digital medical records.
China currently has more than 1.8 million villages, nearly 420,000 township level of government. Meng Jianguo that the county hospital the next five years China\\ s medical equipment, imaging equipment, testing equipment and information technology products, demand will surge, \"this year the state will invest in each county hospital $ 2.5 million, then each Hospital invest $ 2 million. \"
It is reported that Chinese medical device market, currently has capacity of 100 billion yuan, representing a compound annual growth rate of 21%, and drugs, the proportion of 1:10, but the level of developed countries is 1:1, which proves there is tremendous growth in the medical device market space .
\"Currently 60% of China\\ s medical institutions, medical devices are used in the mid-1980s, medical equipment, medical equipment spending in the pharmaceutical industry, the proportion of consumption accounted for only 13%, while the international average of 42%,\" in gold companies to invest directly Yu Chen, managing director, said the future of medical equipment will be VC / PE investment priorities.
Figure days Cen Wang Venture Partners also said that at present most Chinese hospitals use medical equipment mostly imported from abroad, but in fact, some domestic production of small businesses in low-end equipment cost no less than foreign products, investors more should consider providing support to domestic medical device companies.
Policy of social capital into the medical field is not yet clear
December 3, 2010, the State Council issued Document No. 58, that \"to further encourage and guide social capital to hold the views of medical institutions\" to encourage capital to enter the medical profession. Wang Hui, executive director of CDH that national health care reform to the social illusion, but the main problem is the 58 only to document a general direction, but many are not clear supporting policies, so now to talk about social capital into the health care market, Road still a long way.
Phoenix Management Group, Joint Medical Director Jiangtian Fan also believes that the establishment of hospitals and social capital can not completely solve the problem, now a doctor is difficult and expensive not only because of the number of how many medical institutions, more because of lack of capacity of existing health care resources management.
Chart Venture Partners Day Cen Wang also pointed out that the overall policy remains unclear, most organizations can not act rashly, so will spend a longer period of wait and see period.
Chinese medical technology to be different levels of management
Chinese medical technology is expected based on risk level, ease of operation, and clinical use, etc., the different levels of management. State Drug Administration recently released "Chinese medical technology clinical management" (draft), pass out the above information.
According to the "Rules" will be divided into three traditional Chinese medicine diagnosis and treatment technology. Among them, the first level is the safety, effectiveness, precise, simple, low technical difficulty of ordinary skill; second level is safety, effectiveness, exact, but the operation is more complex, there are certain technical difficulties, or involves some ethical issues, or high-risk Chinese medical technology; third level includes the major ethical issues involved in high-risk, complex operation, technical difficulties, safety, effectiveness, by the standards of clinical trials still need further validation studies, or the State Pharmaceutical Authority may require special management needs of other Chinese medical technology.
State Administration of Traditional Chinese Medicine is responsible for formulating, adjusting the classification directory Chinese medical technology, medicine and medical technology is responsible for third-level access management, clinical validation. Provincial Chinese Medicine department responsible for the area within the second level of access to Chinese medical technology management, clinical validation. The first-class medical technology clinical medicine by the medical establishments under the functions, tasks, technical capacity to implement strict management.
"Measure", the application of Chinese medical institutions, medical technology, medical technology and the need to establish Chinese medicine classification management system and the protection of traditional Chinese medical technology clinical quality, safety rules and regulations, the establishment of Chinese medical technology file, the Chinese medical technology on a regular basis for safety, effectiveness and reasonable application of the assessment, reporting and so on.
In addition, the "other five Chinese Acupuncture medical technology classification" period for comments.
Chinese medical technology to be different levels of security as the most senior management
Chinese medical technology is expected based on risk level, ease of operation, and clinical use, etc., the different levels of management. State Drug Administration recently released "Chinese medical technology clinical management" (draft), pass out the above information.
According to the "Rules" will be divided into three traditional Chinese medicine diagnosis and treatment technology. Among them, the first level is the safety, effectiveness, precise, simple, low technical difficulty of ordinary skill; second level is safety, effectiveness, exact, but the operation is more complex, there are certain technical difficulties, or involves some ethical issues, or high-risk Chinese medical technology; third level includes the major ethical issues involved in high-risk, complex operation, technical difficulties, safety, effectiveness, by the standards of clinical trials still need further validation studies, or the State Pharmaceutical Authority may require special management needs of other Chinese medical technology.
State Administration of Traditional Chinese Medicine is responsible for formulating, adjusting the classification directory Chinese medical technology, medicine and medical technology is responsible for third-level access management, clinical validation. Provincial Chinese Medicine department responsible for the area within the second level of access to Chinese medical technology management, clinical validation. The first-class medical technology clinical medicine by the medical establishments under the functions, tasks, technical capacity to implement strict management.
"Measure", the application of Chinese medical institutions, medical technology, medical technology and the need to establish Chinese medicine classification management system and the protection of traditional Chinese medical technology clinical quality, safety rules and regulations, the establishment of Chinese medical technology file, the Chinese medical technology on a regular basis for safety, effectiveness and reasonable application of the assessment, reporting and so on.
Carestream Health s National Oral Health Care
September 20 is our 23rd National "Love Teeth Day" This year s theme is "healthy mouth, happy family." As the world s largest supplier of digital dental effects, CarestreamHealth, Inc. Corporation (Carestream Health), long-term responsibility for oral health care for all the people to action for the medical institutions of various digital dental products and solutions.
Small tooth, the whole body healthy relationship. According to the latest oral epidemiological survey, all the people of China in recent years despite improved oral health, but tooth decay, periodontal disease, prevention and treatment of high disease situation is still grim, Stomatology prevalence rate of 97.6%. Numerous studies showed that oral diseases and certain systemic diseases (such as diabetes, heart disease, stroke, premature birth, low birth weight, etc.).
Regular inspection, early detection and treatment is the best way to have a healthy mouth. Many hospitals and dental clinics, the introduction of professional digital equipment, which, Carestream Health s dental appliance – KODAKK9500 flat cone-beam CT system is widely available. The product uses the industry s most advanced "big vision" three-dimensional system, through which the dentist can easily structure of patients with oral and maxillofacial three-dimensional inspection, quickly generate high-quality, high-resolution three-dimensional images, in order to achieve accurate visualization of the anatomy. With KODAK9500 system, dental oral and maxillofacial doctor can carry out the organizational structure of three-dimensional inspection, simple, safe, affordable on-site large field of three-dimensional inspection has fully become a reality.
Dentist oral camera is now an indispensable tool for the medical examination, Carestream Health recently launched the first high-definition oral endoscope – KODAK1500 become a doctor right-hand man, the product not only has a real auto-focus, You can also automatically provide light, without any manual adjustments for ease of doctors. In addition, eight-in LED light products to ensure the true color images and excellent image quality, while supporting advanced Kodak dental imaging software, the doctor can be a computer or video monitor, easy to modify images and video data, storage and sharing, improve the efficiency of dental treatment.
As all-digital dental imaging products leader, Carestream Health is not only for the performance of medical institutions to provide dental products and solutions, but also to provide thoughtful professional training services to improve the overall level of dental diagnosis. In 2009, Carestream Digital Dental Solutions Training Center in Beijing, providing products for medical training and clinical diagnostic services, including: dental implant in each of the diagnostic imaging unit to carry out training courses in lectures, use of oral CT images and post-processing software designed to operate using the introduction and training; the application has been installed to provide clinical teaching and training clients; regular dental CT professional seminars, the establishment of international and domestic Dental latest technology platform.
Carestream Health s Greater China president Liu Jie said: "Oral health is an important part of human health, not only reflects the quality of life, is an important symbol of modern civilization of mankind based on our deep understanding of the status of residents of the mouth, we have been focused on global the most advanced dental imaging products and solutions development, combined with a high sense of responsibility and Carestream localization strategy in China more hospitals and dental clinics to provide more rapid, convenient, efficient, accurate health care support, continue to promote Chinese public oral health improvement and upgrading. "
GE Healthcare in China starting fiber 1.5T magnetic resonance instrument
September 17, the world s first successful application of radio frequency technology, fiber-optic instrument OpTixMR 1.5T MRI in Beijing for the Chinese market officially released, marking the Chinese 1.5T MRI application to enter the optical fiber from the era.
This reporter has learned this from GE Healthcare global R & D team after many years of technological breakthroughs, GE Healthcare Discovery MR 7503.0T based technology platform to build fiber-optic 1.5T MRI device, a significant shift in the traditional RF magnetic resonance mode, as improve the quality of magnetic resonance imaging, to achieve a higher detection rate of lesions found a new pass.
Industry experts point out, OpTixMR of fiber-optic technology has opened up a 1.5T MRI technology development trend, it is bound to promote the clinical application of magnetic resonance into a deep and sustained innovation.
MRI equipment is the core of radiology equipment, widely used in cardiovascular and cerebrovascular diseases, cancer and other major diseases, early diagnosis. High SNR images can significantly improve the lesion detection rate, higher resolution image, and thus become the most critical areas of magnetic resonance technology competition. After years of exploration, GE Healthcare first to solve the magnetic interference of the optical RF system problems, the optical fiber that has been widely used in information and communication, sensing the introduction of high-tech fields of 1.5T MRI, 1.5T MRI technology to achieve quality the leap.
Conference, talking about China s future demand for MRI devices, industry experts said, compared to the level of developed countries, the popularity of magnetic resonance equipment, China s technological progress and popularity of magnetic resonance applications demand more urgent.
The medical profession: a new speed-related companies benefit from health reform
New medical reform requires 2011 basic medical insurance system is fully covered by urban and rural residents, essential drugs system has been initially established, urban and rural primary care health service system to further improve the basic public health services have been popular, reform of public hospitals to achieve a breakthrough, significantly improve the basic health services, effectively reduce the population burden of medical costs.
From the new medical reform scheduled completion date of less than 5 months. Speed ??and tackling, a "wrap up" before the two key words. As the new medical reform will soon ending, the recent medical reform movements are frequent throughout. Medical industry is a positive change.
Solve the "drug dependent doctors and hospital corporate lack of supervision and other traditional institutional issues is a long-term process, short-term reliance on information technology effectively to improve public hospitals operating efficiency, while through the public health platform for rational allocation of medical resources, a relief" difficult and expensive "an important tool. Expected to "second five" medical information during the market size of about 800 billion yuan, 2010-2013 compound annual growth rate will reach 21%.
Currently 90% of the clinic and hospital admissions are concentrated in the public hospitals, public hospitals and physician workload occupancy rate higher than the average. 1284 almost all tertiary hospitals carried out information technology, and the following nearly 20,000 two hospitals, 80% of information technology has been carried out, HIS systems mature and gradually extend the basic application, CIS system is gradually in-depth application . Recently the Ministry of Health to promote clinical pathway management, information technology will continue to promote the deepening of HIS and CIS applications, the future will also provide primary health care institutions to gradually penetrate the market to further expand capacity.
Public health information technology to help achieve a rational allocation of medical resources. Current rural and community health care system has been basically completed, and significant additional medical resources to rural and community tilt. Two-way classification and referral clinic in the system of guarantees, many cases can be treated in the primary health system, if necessary, and then transferred to larger hospitals. Public health information is the rational allocation of medical resources in an effective way of scheduling, due to a late start and the market is vast, and so the average annual compound growth rate will remain at 50%.
As of the end of 2010, the country participated in urban basic health insurance to 4.3 million people, the number of new agricultural insurance pilot to reach 103 million insured people, personal spending accounted for only 38% of health expenditure per capita, countries are to accelerate the health insurance coverage of urban and rural population. People this year the Department plans to issue 600 million new social security card, and load and to achieve national generic financial capabilities, social security health care information system construction will be fully accelerated.
Investment strategy: in the medical information of listed companies will be a huge market opportunity, we recommend companies include: Wei-ning software, Wanda information, easy to Lianzhong, and recommended that attention Neusoft Group, Silver River shares, UF software.
“The new rural cooperative” calls for medical supply and demand balance
With the rapid economic development, China\\ s rural medical supplies in general has been greatly developed, the number of medical facilities in rural areas than in the past has also been substantially improved.
Township hospitals and village clinics, both in quantity and equipment, personnel, and more in the past have been greatly improved, which is the implementation of the new rural medical system and medical services to meet the needs of farmers played a catalytic role. With the increased income of farmers and national policy support, farmers actively participate in the new rural medical system, the participation rate reached 94%.
Rural health needs analysis
1 Analysis of farmers\\ income
With the rapid economic growth, China\\ s per capita income has steadily increased. Internationally accepted measure of family income, the Engel coefficient, in the past few years, China\\ s Engel coefficient showed an overall downward trend, in which the Engel coefficient of rural households from 58.8 in 1990 dropped to 41.0 in 2009. This reflects the general improvement of rural household income and living conditions improved.
(2) factors affecting rural health care needs
In addition to income factors affecting the demand for medical services of rural residents there are many factors, for example, transportation convenience, and cultural level of farmers, rural medical equipment as well as the aging population, environmental pollution.
(1) transportation of
At present, China\\ s rural traffic conditions than in the past has been greatly improved, some areas have achieved the \"village road.\" A convenient traffic conditions can effectively improve the farmers\\ demand for medical services.
(2) The cultural level of farmers
Culture can influence the level of a person made a decision. With the general cultural level of our population increase, the physical condition of the farmers for their understanding and level of quality of life has a significant increase, from the subjective improve medical and health services.
(3) rural medical condition
Rural medical conditions, including: the level of rural medical staff, medical facilities, as well as medical expenses. Higher level of medical personnel, medical facilities certain and reasonable medical expenses, to ensure that farmers demand for medical services.
(4) aging of the population
China has entered an aging society, changes in age structure, the average age will increase significantly from the objective to increase the people\\ s demand for medical care. And a young society will reduce the demand for medical services.
(5) environmental pollution
As we all know, the current global environment than 10 years ago has undergone tremendous changes. Environment has been damaged, a serious threat to human survival. Poor living conditions gave rise to a greater threat of disease. Corresponding demand for medical services will also increase.
\"The new rural cooperative\" with the rural health care supply and demand analysis
Because of asymmetric information between doctors and patients as well as the level of rural health status, lack of farmers\\ right to choose medical services. Today, China mainly through the new rural cooperative medical care for rural residents to protect and reduce their health care burden. Farmers have to go to the designated patient medical health insurance unit, which contributed to the cooperative medical supply-side advantages.
\"The new rural cooperative\" to protect illness was mainly Paul inpatient medical services, and service needs of ill health, mainly in the county level or above designated cooperative medical designated hospitals, these hospitals are likely to cause a shortage of medical services, inadequate supply of . A direct consequence of the inadequate supply of health care transaction costs in disguise, leading farmers in the reduction of benefits from the medical cooperation, reduce the system gain. Therefore, the \"new rural cooperative \\ implementation will increase above the county level the number of designated medical institutions for medical care, thereby reducing the township hospitals and village clinics needs.
Development proposals in rural health care
1 step up publicity efforts to guide farmers to voluntarily participate in the \"new rural cooperative.\"
Farmers to voluntarily participate in the new rural cooperative medical care, we must first understand the \"new rural cooperative.\" Government to increase the \"new rural cooperative\" policy advocacy efforts, by farmers from the \"new rural cooperative\" in the typical case of access to affordable, so that farmers really recognized that participation in the \"new rural cooperative,\" the importance of the \"new rural cooperative\" system enjoys popular support, so that farmers understand and accept. We should actively guide farmers to change the traditional ideas, eliminate ideological concerns, continue to strengthen the awareness of risk diversification, voluntary participation, \"the new rural cooperative.\"
It should be said that China, after years of publicity and promote the work of rural residents generally accepted the new rural cooperative medical care policy, but as to how the specific level of compensation and compensation, the majority of farmers still unclear. Must step up publicity efforts, the highly professional user-friendly way to explain the policy to make clear the majority of farmers.
(2) to enhance the standard management of medical services
The Government should strengthen the designated medical service behavior and the regulation of drug prices, medical services and medicines as a special commodity, its difficult for farmers to make a choice, you need government regulation. The Government should strengthen the rural health institutions, medical personnel, health technology and other aspects of access management, adherence to quality and price of drugs, medicine, rational drug use, medical service prices and charges behavior management and supervision, to crack down on counterfeit and fake health advertising, medical drug farmers to ensure safety and increase farmers\\ new rural cooperative \"system of trust.
At the same time, strengthen the non-government private health sector management, improve and perfect the relevant laws and regulations, laws and regulations such as the health care market, pharmaceutical market laws and regulations, health laws and regulations of the talent market, so as to adapt to the rapid development of medical and health development, security healthcare industry healthy and orderly growth.
3 to improve funding levels, improve the financial management mechanism
In the \"new rural cooperative\" fund-raising process is prone to the problem of insufficient funding, the government needs to improve the \"new rural cooperative\" level of funding, especially in poor areas appropriate for increased subsidies, while actively raising the Social Fund. Fund operations in the process, prone to misappropriation of funds and abuse of other issues.
Therefore, while the government should expand the financing channels, making the farmers from the \"new rural cooperative\" in the real tangible benefits, so as to attract greater demand; the other hand, should strengthen the management of funds, so that the whole cooperative medical care system public, and to prevent incidents of corruption, to ensure the safe operation of medical funds.
Health care into the digital factory of Taiwan into the mainland Chinese market cut-off point of Things
.jpg "surgery sutures")
Straight sets in the global market economy, debt crisis in Europe did not understand the delay, making the advanced countries, the government eager to tighten the money supply, domestic investment projects have slowed down. And this wave of mainland China under the threat of economic recession, is still investing heavily in ICT industry based in the seven strategic goals, attempts to expand the domestic market taking advantage of the sky.
\"Second five\" business opportunities leveraging digital medical industry
\"Second five\" Plan involving medical information are: (1) strengthening of rural and community health agencies of information technology; (2) to establish electronic medical records and files of home health focus; (3) development of regional health care resource sharing ; (4) promote the city\\ s hospitals and community health agencies, to ensure that telemedicine services. In the Internet, collaboration, prevention, universal, innovative and reliable medical care of the six characteristics of the intelligent platform, gave birth to three applications of networking technology: medical equipment and drugs, supervision and management, remote medical monitoring, digital hospital.
Bears the number 120 one hundred million yuan business health care industry, is cut into the mainland China and Taiwan factory of things the market a chance to point. Continent \"new medical reform\" will match \"Healthy China 2020\" development goals, to promote policy-oriented reform program during the second five will invest 8,500 billion yuan, strategic planning in this manner to enhance the standard of care in mainland China.
From the perspective of industry chain, industry chain into the medical digital components, equipment, software systems, transmission technology, application services five major areas, including software systems benefit the most, followed by the device. Topology, said medical software systems for the digital core, taking into account the medical system safety and reliability requirements, the majority of software systems give priority to self-produced products in China, the market focused on providing complete solutions for manufacturers. Among manufacturers in China, Neusoft Medical Systems and UF highest share health information systems.
Equipment is divided into interface devices and core devices, medical equipment manufacturers mainland mostly concentrated in the interface equipment supply, rarely studied under the core equipment, core equipment space part of import substitution, but the technology lies in the foreign countries, but also to large-scale development needs time, Topology promising technology and first-mover advantage with the business.
The face of the huge number of Chinese mainland business opportunities in health care, medical units and ICT companies in Taiwan in recent years, has accumulated rich experience in the medical intelligence, with the cross-strait exchanges and cooperation in health development, there are a number of Taiwan-funded enterprises have to join the mainland medical industry, For example, Inventec, Taiwan factory Gade technology, Syscom Computer and other companies. Topology that want to enter the Chinese medical market intelligence vendors, strategic alliances can be used to do the integration of resources, R & D centers recruit local talent, the first cut into small modules and dimethyl hospital system, or cooperate with China to establish Taiwan Hospital Success Stories etc., then came to embrace a new blue ocean opportunities.
Zhang Guangping Topology Research Institute, said the future of software and hardware integration technology industry is definitely an important issue, based on the urgent needs of ICT infrastructure, gradually introduced the \"second five\" Plan the implementation of projects which, either from the the scale of investment and five-second market point of view, things will be one of the biggest beneficiaries, in 2015 the market size will reach 8,000 billion yuan, compared with 174% growth in 2011. Among them, the construction of smart grid as an investment choice in 2015, including sensors, systems and test for detection, chip and middleware, Serve modules and equipment industry output will reach 200 billion yuan.
Investment in smart grid building the largest strength
During the second five is a comprehensive smart grid construction period, will be active in establishing technical standards, as well as the development of key technologies and equipment. Benefits include special high-voltage equipment, substation intelligent, smart meters, distribution automation, and the charging station and charge pile. One application of intelligent substation is the things to invest part of the largest strength, market size of 7.4 billion yuan, during the second five choice for smart grid investment, enterprise technology and channel capacity is the key to winning.
Smart power is the largest applications of things, including the role of smart meters with sensors, smart electricity based equipment, five-second market after the intelligent substation, up to 600 billion yuan. Topology, said smart meters with low entry barriers, market competition, more suitable for a first-mover advantage and cost control of the enterprise.
Topology pointed out that the smart grid industry chain, in UHV power grid equipment, mainland China and Taiwan factory is more difficult to cut into the market, but sensing components and control components is the most widely used part for China and Taiwan plants in the field of development, the smart grid can be said that a big advantage. In addition, China Taiwan now has a meter manufacturing technology, the basis of smart meters and related equipment are sets of plant distribution advantage, relying on this technology can be cut into the mainland market, the smart grid.
Beauty Yixie five hot economic growth emerge
Cosmetic medical device market is a relatively young market, but the development speed. In 2009, the global beauty medical equipment market generated total sales of $ 1.8 billion in 2010, nearly $ 2 billion. According to F & S predicts that by 2016, global beauty medical equipment market will reach $ 4.9 billion, an annual growth rate above 7%.
Of particular note is that in the past few years, although the United States and Europe, economic stagnation, the global beauty medical equipment market remains a growth trend. Western economic analysts speculated that this may be related, including China, Brazil, India and other emerging economies and the European medical device products for the beauty needs of the powerful.
Beauty in the medical device market in Europe and America developed the verge of saturation, the international medical device industry in China, Japan, Korea, Hong Kong, China and Southeast Asia have high hopes.
Outstanding contribution to skin care equipment
Medical device market in the beauty, a beauty should not be overlooked factor is the rise of the global device products skin care devices market in new contributions. Laser beauty equipment is now increasingly used in skin care, cosmetic surgery, removal of scars and birthmarks such as silicone filled breast surgery. These cosmetic surgery for cosmetic medical products of great social demand.
For example, micro-injection of neurotoxins such as botulinum toxin cosmetic surgery has been all the rage, although expensive, but do Botox cosmetic surgery still rush. To this end, designed for injection of botulinum toxin, hyaluronic acid or collagen syringes and other cosmetic drugs, special sales doubled.
There are three major global skin care market – the United States, Europe and Japan, the world\\ s three major markets together accounted for 87% of skin care market. Currently, the only European manufacturer of laser beauty equipment as a key product development, a number of emerging economies will also focus on the development of laser beauty equipment as medical devices. In recent years, with the rapid economic development in East Asia, South Korea and other East Asian countries are now dominated by the skin of the beauty industry to flourish. At the same time, and skin care industry for the production of medical devices have begun to fast track.
In addition, some of the more affluent countries in Southeast Asia such as Singapore and Malaysia, the number of cosmetic surgery to do skin is also rising rapidly, and thus promote skin cosmetic surgery device market in Asia\\ s rapid growth.
It is understood that low-power laser skin cosmetic surgery is the most commonly used equipment products, estimated sales in recent years around the world each year millions of cosmetic surgery on the use of laser products, such as carbon dioxide lasers, ruby ??lasers and newly developed semiconductor lasers and so on.
China has become the world\\ s leading producer of laser products and markets, not only the production of industrial lasers, and lasers can produce a variety of skin care products are the domestic annual production of only medical laser product that is more than 10 million units, the product not only for domestic use, there are some products exported. Statistics show that China can produce international beauty industry-wide YAG (1064nm) laser skin care machine, and a variety of Lipstick CO2 laser surgery required, and all kinds of semiconductor lasers and other medical, cosmetic surgery of the size of the laser product.
In 2010, China laser product sales topped 2 billion yuan mark. Clearly, China and the International Civil laser products and technology gap is narrowing.
Map of the five growth poles emerge
Developed countries in Europe and America the brink of beauty medical equipment market saturation point in the case, the international medical device industry has been China, Japan, Korea, Hong Kong, China and Southeast Asia as a cosmetic medical device market growth of 5 new hot spots and high hopes.
According to the International Medical Device Industry experts predict, although in 2016 the U.S. will remain the world\\ s largest cosmetic medical device market, but China and Brazil will become the world\\ s beauty medical equipment on the market a new growth pole, the two countries to cosmetic medical device market 2016 will reach $ 796 million and $ 572 million; India with its large population and rapid development of the national economy, its beauty medical equipment market in 2016 will increase to $ 200 million. Most of ten countries in Southeast Asia is lagging behind economic development, but analysts remain bullish on foreign economic beauty of the region\\ s medical device market, think of the region\\ s beauty medical equipment market in five years is expected to reach $ 200 million in sales.
Europe as a major traditional medical device market, although most of the country\\ s economic stagnation, but after five years in Europe cosmetic medical device market will exceed $ 1 billion. Japan in recent years suffered a series of strong earthquakes, tsunami and stop economic development and other negative factors, it is estimated the country\\ s beauty market sales of medical equipment after five years than it is now in decline $ 29 million.
Experts also predict that the next five years is expected to maintain rapid growth of beauty and health equipment products are: all kinds of gases, solids, semiconductor lasers class cosmetic medical products, they are beauty products, the backbone of the medical device components; followed by a variety of tender cosmetic skin surgery-specific products and equipment for injection of botulinum toxin, hyaluronic acid and collagen-specific drugs such as syringes beauty products, silicone (filled breast surgery) special syringe liposuction surgery special suction machine, optical quantum generators and other products.
“Eleventh Five” Medical Device Regulatory Review
Review of medical device regulation, \"Eleventh Five\" process, Yue Wei has strong feelings: \"This year, medical supervision is taking a start from the bottom, climbing step by step the road, though experiencing some setbacks, but still made to make people were proud of the achievements: medical devices carried out special rectification, reinforced by standards, testing technical support system for the core and build the regulatory framework for in vitro diagnostic reagents, introduced the \"Medical Device Good Manufacturing Practice\", etc. It can be said, five years, medical supervision is tempered in advance. \"
Indeed, the \"Eleventh Five-Year\" period, China\\ s medical device regulatory system to the base from the regulatory progress, from the detection system to routine monitoring, from registration to adverse events monitoring, management of all aspects of breakthrough medical device to promote the cause the pace of progress monitoring.
- The progress of laws and regulations. In 2006, \"Supervision and Regulation of Medical Devices\" revision started. 5 years, relevant departments have organized a survey of 34 key topics. In September, the State Council Legislative Affairs Office on \"Supervision and Regulation of Medical Devices (Amendment Bill)\" to the public for comments. In 2007, the State Food and Drug Administration issued an \"in vitro diagnostic reagents production implementation of the Rules (Trial)\", \"in vitro diagnostic reagent system for assessing the implementation of quality management\" and the \"in vitro diagnostic reagents for the evaluation of production quality system standards\", perfected in vitro supervision and regulation system diagnostic reagents for in vitro diagnostic reagents to enhance the production quality management system to provide a regulatory basis for the realization of the whole process of regulation, in vitro diagnostic reagents continue to promote the improvement of product quality and industrial health regulations laid a foundation. December 2009, the State Food and Drug Administration issued a \"Medical Device Good Manufacturing Practice (Trial)\" and its supporting documents and a series of normative documents for quality at the source, to achieve the final product from the regulatory supervision of the whole process change, and constantly promote the quality of medical products and medical devices to improve the healthy development of the industry laid the basis for laws and regulations.
- Standard construction progress. Past five years, the standardization of medical devices has been an unprecedented development. Before 2004, China has no standards of medical device materials. \"Eleventh Five-Year\" period, the State Food and Drug Administration successfully applied for a special state finance \"national medical device standard, standard calibration and review projects,\" the field of medical devices to create a standard material, in particular, medical laboratory and clinical testing in vitro diagnostic system of Standard Material new situation. Currently, medical devices are being developed over 20 kinds of standard materials. Among them, ethylene oxide standard material has been approved, became the first medical device approved reference material. In 2009, the global outbreak of H1N1 flu. In response to this public health emergencies, the State Food and Drug Administration and health department to establish the diagnosis of infectious diseases associated with the H1N1 influenza virus nucleic acid national reference materials, and have been approved. This is accomplished for China to establish joint prevention and control of major infectious diseases quickly laid the foundation system. This is the standardization of medical equipment in the \"Eleventh Five-Year\" period of the outstanding achievements and significant contributions. December 2009, the State Food and Drug Administration Medical Device Management Center was established standards. As of December 2009, China has issued national standards for medical device 180, the industry standard 727, covering the medical devices included in Categories 306 categories of medical device products, initially formed with a certain coverage standards.
- Register review progress. With the administrative rules and regulations of the enrichment and improvement of registration procedures, registration of medical devices approval process to change the original administrative acceptance, technical evaluation and administrative examination and approval, \"bundle\" model, to achieve the sub-management, namely, administrative acceptance, technical review evaluation and administrative examination and approval of the three separated. Work in the evaluation and approval to implement the \"three systems a\", that staff review the trial implementation of collective responsibility, to prevent the abuse of power by individuals; implement accountability system evaluation and approval, the approval of illegal acts to strengthen accountability; pre-trial assessment system and approval of inspectors to avoid publicity system; promote information technology evaluation and approval, the full implementation of online acceptance, approval online, online publicity. Implementation of sub-management, implementation of the \"three systems one of the\" registration of medical devices in order to ensure open, fair, impartial, and lay a good foundation.
- Daily monitoring of progress. There has been a long time to resolve the re-approval of light regulation, medical device manufacturers to strengthen the daily supervision, to ensure the quality of medical products, the State Food and Drug Administration in 2006 issued a revised \"day to day supervision and management of medical device manufacturing requirements.\" clear national and provincial, city and county regulatory authorities at all levels of daily supervisory duties, clear the routine supervision and inspection of the scope, focus, content, timing and frequency of supervision and inspection requirements. To strengthen the high-risk medical device manufacturer\\ s production control, the past five years, the State Food and Drug Administration has successively organized a variety of vascular stents and other key production quality management system of special inspections. In 2009, the State Food and Drug Administration organization released one after another in recent years the focus of control varieties were re-screened, reviewed, revised release of the \"National regulatory medical device directory (2009 edition)\", as the regulatory authorities at all levels to implement high-risk products provide a basis for focused regulation.
- Adverse event monitoring progress. In 2006, the State Food and Drug Administration issued a \"Circular on Further Strengthening of medical device adverse event monitoring related issues notice\", in addition to calls for further strengthening of medical device adverse event monitoring, it also proposed a medical device adverse event monitoring and recall of relevant requirements, the initial establishment of a medical device recall reporting system. December 29, 2008, \"Medical Device Adverse Event Monitoring and re-evaluation of management (tentative)\" by the State Food and Drug Administration and the Ministry of Health jointly promulgated, filled the adverse event monitoring and re-evaluation of regulatory gaps. 2005 to 2009, the state central database receives each year the number of reports of suspected adverse events were increased from 1887 to 60,305 copies, the cumulative total of 121,607 copies. As of the end of 2009, a total of 34 provincial-level implementation monitoring body, set up in parts of the city, county, township monitoring bodies, which cover the lower to monitoring bodies, 11 municipal, to cover the county (district) grade 13, to cover the township (town) level four.
In the tempered forward, in advance breakthrough. It is this all break, and constantly reinforce the medical device regulatory basis for progress. The next five years, will achieve new breakthroughs.